PTI 701

Drug Profile

PTI 701

Latest Information Update: 21 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Albert Einstein College of Medicine; Pain Therapeutics
  • Developer Pain Therapeutics
  • Class
  • Mechanism of Action Opioid receptor agonists; Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 21 Nov 2006 Discontinued - Phase-II for Pain in USA (PO)
  • 06 Nov 2002 This compound is still in active development
  • 12 Oct 2000 Phase-II clinical trials for Pain in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top